Radhika Korupolu

Rani Therapeutics (United States)

Papers

1

Total Citations

94

H-Index

1

About

Dr. Radhika Korupolu is pioneering the frontier of oral biotherapeutic delivery, a field long constrained by the painful reality of chronic injections. Her landmark work, "A robotic pill for oral delivery of biotherapeutics," with 94 citations, demonstrates a transformative approach to patient compliance. This research introduces a self-orienting, millimeter-scale robotic device that safely and tolerably delivers biotherapeutics directly into the gastrointestinal lining, bypassing enzymatic degradation. By engineering this ingestible platform, Dr. Korupolu addresses a critical bottleneck in drug administration—the degradation of large-molecule drugs in the GI tract. Her contributions are not merely technical; they represent a paradigm shift toward painless, patient-friendly management of chronic diseases. The impact of her work is evident in its rapid citation and its potential to replace injections for conditions like diabetes and autoimmune disorders. Dr. Korupolu’s innovation stands as a testament to the power of bioengineering to solve real-world clinical challenges, offering a future where effective biotherapeutics can be taken as easily as a daily pill.

Research Focus

Key Achievements

1
H-Index
1
Papers
94
Total Citations
94
Avg Citations/Paper
🏆 Most Cited Paper
A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects
94 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Rani Therapeutics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago